Zhu Nina J, McLeod Monsey, McNulty Cliodna A M, Lecky Donna M, Holmes Alison H, Ahmad Raheelah
National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London W12 0NN, UK.
Centre for Medication Safety and Service Quality, Pharmacy Department, Imperial College Healthcare NHS Trust, London W12 0NN, UK.
Antibiotics (Basel). 2021 Jan 1;10(1):32. doi: 10.3390/antibiotics10010032.
We describe the trend of antibiotic prescribing in out-of-hours (OOH) general practices (GP) before and during England's first wave of the COVID-19 pandemic. We analysed practice-level prescribing records between January 2016 to June 2020 to report the trends for the total prescribing volume, prescribing of broad-spectrum antibiotics and key agents included in the national Quality Premium. We performed a time-series analysis to detect measurable changes in the prescribing volume associated with COVID-19. Before COVID-19, the total prescribing volume and the percentage of broad-spectrum antibiotics continued to decrease in-hours (IH). The prescribing of broad-spectrum antibiotics was higher in OOH (OOH: 10.1%, IH: 8.7%), but a consistent decrease in the trimethoprim-to-nitrofurantoin ratio was observed OOH. The OOH antibiotic prescribing volume diverged from the historical trend in March 2020 and started to decrease by 5088 items per month. Broad-spectrum antibiotic prescribing started to increase in OOH and IH. In OOH, co-amoxiclav and doxycycline peaked in March to May in 2020, which was out of sync with seasonality peaks (Winter) in previous years. While this increase might be explained by the implementation of the national guideline to use co-amoxiclav and doxycycline to manage pneumonia in the community during COVID-19, further investigation is required to see whether the observed reduction in OOH antibiotic prescribing persists and how this reduction might influence antimicrobial resistance and patient outcomes.
我们描述了在英国第一波新冠疫情之前及期间,非工作时间(OOH)全科医疗(GP)中抗生素处方的趋势。我们分析了2016年1月至2020年6月期间的诊所层面处方记录,以报告总处方量、广谱抗生素处方以及国家质量奖励计划中包含的关键药物的处方趋势。我们进行了时间序列分析,以检测与新冠疫情相关的处方量的可测量变化。在新冠疫情之前,工作时间内(IH)的总处方量和广谱抗生素的百分比持续下降。非工作时间的广谱抗生素处方率更高(非工作时间:10.1%,工作时间:8.7%),但在非工作时间观察到甲氧苄啶与呋喃妥因的比例持续下降。2020年3月,非工作时间的抗生素处方量偏离了历史趋势,开始每月减少5088项。非工作时间和工作时间内的广谱抗生素处方开始增加。在非工作时间,阿莫西林克拉维酸钾和多西环素在2020年3月至5月达到峰值,这与前几年的季节性峰值(冬季)不同步。虽然这种增加可能是由于在新冠疫情期间实施了国家指南,使用阿莫西林克拉维酸钾和多西环素在社区治疗肺炎,但需要进一步调查以确定观察到的非工作时间抗生素处方减少是否持续,以及这种减少可能如何影响抗菌药物耐药性和患者预后。